BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 29851752)

  • 1. Application of the Eighth Edition of the American Joint Committee on Cancer Staging for Pancreatic Adenocarcinoma.
    Liu C; Cheng H; Jin K; Guo M; Lu Y; Wang Z; Yang C; Long J; Ni Q; Yu X; Luo G
    Pancreas; 2018 Jul; 47(6):742-747. PubMed ID: 29851752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International Validation of the Eighth Edition of the American Joint Committee on Cancer (AJCC) TNM Staging System in Patients With Resected Pancreatic Cancer.
    van Roessel S; Kasumova GG; Verheij J; Najarian RM; Maggino L; de Pastena M; Malleo G; Marchegiani G; Salvia R; Ng SC; de Geus SW; Lof S; Giovinazzo F; van Dam JL; Kent TS; Busch OR; van Eijck CH; Koerkamp BG; Abu Hilal M; Bassi C; Tseng JF; Besselink MG
    JAMA Surg; 2018 Dec; 153(12):e183617. PubMed ID: 30285076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the eighth edition of the AJCC staging system for patients with pancreatic adenocarcinoma initially receiving chemoradiotherapy and proposal of modifications.
    Zhu X; Chen D; Cao Y; Zhao X; Ju X; Shen Y; Cao F; Qing S; Fang F; Jia Z; Zhang H
    Cancer Biol Med; 2020 May; 17(2):492-500. PubMed ID: 32587784
    [No Abstract]   [Full Text] [Related]  

  • 4. Projecting Survival in Papillary Thyroid Cancer: A Comparison of the Seventh and Eighth Editions of the American Joint Commission on Cancer/Union for International Cancer Control Staging Systems in Two Contemporary National Patient Cohorts.
    Pontius LN; Oyekunle TO; Thomas SM; Stang MT; Scheri RP; Roman SA; Sosa JA
    Thyroid; 2017 Nov; 27(11):1408-1416. PubMed ID: 28891405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the 8th AJCC staging system for pathologically versus clinically staged pancreatic adenocarcinoma: A time to revisit a dogma?
    Abdel-Rahman O
    Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):64-69. PubMed ID: 29428107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the American Joint Commission on Cancer (AJCC) 8th Edition Staging System for Patients with Pancreatic Adenocarcinoma: A Surveillance, Epidemiology and End Results (SEER) Analysis.
    Kamarajah SK; Burns WR; Frankel TL; Cho CS; Nathan H
    Ann Surg Oncol; 2017 Jul; 24(7):2023-2030. PubMed ID: 28213792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the prognostic value of the new AJCC 8th edition staging system for patients with pancreatic adenocarcinoma; a need to subclassify stage III?
    Song M; Yoon SB; Lee IS; Hong TH; Choi HJ; Choi MH; Lee MA; Jung ES; Choi MG
    Eur J Cancer; 2018 Nov; 104():62-69. PubMed ID: 30326370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the American Joint Committee on Cancer eighth edition staging system in patients undergoing hepatectomy for hepatocellular carcinoma: a US population-based study.
    Zhang G; Li R; Zhao X; Meng S; Ye J; Zhao L
    J Surg Res; 2018 Feb; 222():55-68. PubMed ID: 29273376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-institutional Validation Study of the American Joint Commission on Cancer (8th Edition) Changes for T and N Staging in Patients With Pancreatic Adenocarcinoma.
    Allen PJ; Kuk D; Castillo CF; Basturk O; Wolfgang CL; Cameron JL; Lillemoe KD; Ferrone CR; Morales-Oyarvide V; He J; Weiss MJ; Hruban RH; Gönen M; Klimstra DS; Mino-Kenudson M
    Ann Surg; 2017 Jan; 265(1):185-191. PubMed ID: 27163957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the eighth edition of the American Joint Committee on Cancer staging system and proposal of an improved staging system for pancreatic ductal adenocarcinoma.
    Park MY; Shin SH; Song KB; Hwang D; Lee JH; Lee YJ; Kim SC
    Ann Hepatobiliary Pancreat Surg; 2019 Feb; 23(1):46-55. PubMed ID: 30863807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the eighth clinical American Joint Committee on Cancer stage grouping for esophageal cancer.
    Oweira H; Schmidt J; Mehrabi A; Kulaksiz H; Schneider P; Schöb O; Giryes A; Abdel-Rahman O
    Future Oncol; 2018 Jan; 14(1):65-75. PubMed ID: 29235888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the 6th edition AJCC Pancreatic Cancer Staging System: report from the National Cancer Database.
    Bilimoria KY; Bentrem DJ; Ko CY; Ritchey J; Stewart AK; Winchester DP; Talamonti MS
    Cancer; 2007 Aug; 110(4):738-44. PubMed ID: 17580363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proposal of a modified American Joint Committee on Cancer staging scheme for resectable pancreatic ductal adenocarcinoma with a lymph node ratio-based N classification: A retrospective cohort study.
    Li HJ; Chen YT; Yuan SQ
    Medicine (Baltimore); 2018 Aug; 97(34):e12094. PubMed ID: 30142869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modified Staging Classification for Pancreatic Neuroendocrine Tumors on the Basis of the American Joint Committee on Cancer and European Neuroendocrine Tumor Society Systems.
    Luo G; Javed A; Strosberg JR; Jin K; Zhang Y; Liu C; Xu J; Soares K; Weiss MJ; Zheng L; Wolfgang CL; Cives M; Wong J; Wang W; Sun J; Shao C; Wang W; Tan H; Li J; Ni Q; Shen L; Chen M; He J; Chen J; Yu X
    J Clin Oncol; 2017 Jan; 35(3):274-280. PubMed ID: 27646952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Equipping the American Joint Committee on Cancer staging for resectable pancreatic ductal adenocarcinoma with tumor grade: a recursive partitioning analysis.
    Chen YT; Huang ZP; Zhou ZW; He MM
    Med Oncol; 2016 Nov; 33(11):122. PubMed ID: 27730526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenterico-portal vein invasion should be an important factor in TNM staging for pancreatic ductal adenocarcinoma: Proposed modification of the 8
    Chen HY; Wang X; Zhang H; Liu XB; Tan CL
    World J Gastroenterol; 2019 Dec; 25(46):6752-6766. PubMed ID: 31857777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Interpretation and evaluation of the American Joint committee on Cancer (AJCC) 8th Edition Staging System for patients with gastroenteropancreatic neuroendocrine tumors].
    Chen L; Zhou Z; Chen J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):972-976. PubMed ID: 28900985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the American Joint Commission on Cancer 8th Edition Staging System for Patients with Pancreatic Neuroendocrine Tumors: A Surveillance, Epidemiology, and End Results analysis.
    Li X; Gou S; Liu Z; Ye Z; Wang C
    Cancer Med; 2018 Mar; 7(3):626-634. PubMed ID: 29380547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimized modification of the eighth edition of AJCC TNM staging system for resected pancreatic ductal adenocarcinoma.
    Pu N; Yin L; Habib JR; Gao S; Hu H; Zhu Y; Wu Y; Yu J; Lou W
    Future Oncol; 2019 Oct; 15(30):3457-3465. PubMed ID: 31460788
    [No Abstract]   [Full Text] [Related]  

  • 20. Validation of the American Joint Committee on Cancer (AJCC) 8th edition stage system for gastric cancer patients: a population-based analysis.
    He X; Wu W; Lin Z; Ding Y; Si J; Sun LM
    Gastric Cancer; 2018 May; 21(3):391-400. PubMed ID: 29052053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.